Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Squamous Cell Carcinoma of Head and Neck 7Rectal Neoplasms 7Oropharyngeal Neoplasms 7Head and Neck Neoplasms 6Carcinoma, Non-Small-Cell Lung 5Pancreatic Neoplasms 3Lung Neoplasms 3Hypopharyngeal Neoplasms 3Glioblastoma 3Esophageal Neoplasms 3Uterine Cervical Neoplasms 2Stomach Neoplasms 2Radiation Injuries 2Pathologic Complete Response 2Nasopharyngeal Carcinoma 2Mouth Neoplasms 2Laryngeal Neoplasms 2Vaginal Neoplasms 1Uterine Cervical Dysplasia 1Urinary Bladder Neoplasms 1Tobacco Use Disorder 1Thymoma 1Smoking Cessation 1Smoking 1Small Cell Lung Carcinoma 1Sinonasal undifferentiated carcinoma 1Sinonasal Squamous Cell Carcinoma 1Resectable Esophageal Cancer 1Rectal Malignant Neoplasms 1Postoperative Complications 1

Interventions

pembrolizumab 4Cyclophosphamide 4Radiotherapy 3Cisplatin 3fludarabine 2Doxorubicin 2Carboplatin 2zimberelimab 1olaparib 1lenvatinib 1envafolimab 1avelumab 1Thymectomy 1Taxes 1Sunitinib 1Robotic Surgical Procedures 1Ramucirumab 1Radiotherapy, Adjuvant 1Paclitaxel 1Nivolumab 1Magnetic Resonance Spectroscopy 1Etoposide 1Drug Therapy 1Chemoradiotherapy 1Cetuximab 1AP 1903 reagent 1130-nm albumin-bound paclitaxel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Thymoma × Chemoradiotherapy × 1 year × Clear all
NCT07479628 2026-03-18

Neoadjuvant Adebrelimab Plus CRT for Locally Advanced Thymic Carcinoma

Shanghai Chest Hospital

Phase 2 Not yet recruiting
31 enrolled
Thoracic

Thymoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡